08:00 , Nov 25, 2013 |  BC Week In Review  |  Company News

Avesthagen, Elpen Pharmaceutical Co. Inc. sales and marketing update

Avesthagen granted rights to Elpen to distribute biosimilar Avdesp in Greece, Cyprus, Bulgaria, Romania, Croatia, Slovenia, Slovakia, Serbia, Bosnia, Albania, Macedonia, Montenegro and Kosovo. Avdesp is a biosimilar of anemia drug Aranesp darbepoetin alfa, a...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Company News

Avesthagen sales and marketing update

Avesthagen launched its Whole Genome Scanning service in India. The service, which uses technology from Affymetrix Inc. (NASDAQ:AFFX, Santa Clara, Calif.), is available directly to consumers for $1,000. Avesthagen Ltd. , Bangalore, India   Business:...
07:00 , Mar 28, 2011 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Bristol-Myers Squibb Co. (NYSE: BMY) gained $1.56 to $27.29 last week after FDA approved a BLA for IV Yervoy ipilimumab as first-line therapy for unresectable or metastatic melanoma. The approval includes a REMS...
00:38 , Mar 24, 2011 |  BC Extra  |  Company News

Avesthagen launches whole genome sequencing service

Avesthagen Ltd. (Bangalore, India) launched its Whole Genome Scanning service in India. The service, which uses technology from Affymetrix Inc. (NASDAQ:AFFX), is available directly to consumers for $1,000. Affymetrix was up $0.07 to $4.52 on...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Clinical News

Avdesp: Phase III start

Next quarter, Avesthagen will begin a double-blind, active-controlled, Indian Phase III trial of Avdesp. Avesthagen Ltd. , Bangalore, India   Product: Avdesp   Business: Hematology   Molecular target: NA   Description: Biosimilar of darbepoetin alfa,...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Clinical News

Avdesp: Phase III start

Next quarter, Avesthagen will begin a double-blind, active-controlled, Indian Phase III trial of Avdesp. Avesthagen Ltd. , Bangalore, India   Product: Avdesp   Business: Hematology   Molecular target: NA   Description: Biosimilar of darbepoetin alfa,...
08:00 , Jan 29, 2007 |  BioCentury  |  Strategy

Outsourcing money

Avestha Gengraine Technologies Pvt. Ltd. intends to tap into both Indias traditional medicines heritage, and the international contacts of its founder and managing director Villoo Morawala Patell to become a global biotech company. With no...
08:00 , Feb 17, 2005 |  BC Extra  |  Company News

Avestha appoints CFO, COO

Predictive medicine company Avestha (Bangalore, India) hired J. Rajagopalan as CFO and general manager of administration, and Gilles Amsallem as COO. Avestha CEO Villoo Morawala Patell said the new hires will oversee the company's three...